MID-VOLUME · FEMALE-LED
vilazodone Side Effects
vilazodone (also sold as Viibryd) sits MID-VOLUME #324 of 524 by FAERS report count. Lead signal: FEMALE-LED - 72% of sex-coded reports are female (6,520 F / 2,551 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 9,764
- FAERS reports
FDA Adverse Event Reporting System extract for vilazodone. Stamp set WATCHLIST · DEATH-MARKED · HOSP-MID. How figures are compiled.
vilazodone reporting skew - 72% of sex-coded reports are female (6,520 F / 2,551 M). Volume band MID-VOLUME #324 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for vilazodone (Viibryd) (9,764 reports). Signature FEMALE-LED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2009–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
DIARRHOEA leads 808 of 9,764 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (72% of sex-coded rows)
Age peak 45-64 (2,351 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 328 reports (3.4% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| COMPLETED SUICIDE | 174 |
| DEATH | 77 |
| TOXICITY TO VARIOUS AGENTS | 38 |
| CARDIO-RESPIRATORY ARREST | 22 |
| CARDIAC ARREST | 15 |
| OVERDOSE | 15 |
| SUSPECTED SUICIDE | 13 |
| RESPIRATORY ARREST | 10 |
| ACUTE KIDNEY INJURY | 8 |
| GUN SHOT WOUND | 8 |
| INTENTIONAL OVERDOSE | 8 |
| FATIGUE | 7 |
| HYPERTHERMIA | 6 |
| HYPOTENSION | 6 |
| NAUSEA | 6 |
| PNEUMONIA | 6 |
| PULMONARY OEDEMA | 6 |
| RENAL FAILURE | 6 |
| BRADYCARDIA | 5 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,195, 12.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| NAUSEA | 90 |
| ANXIETY | 86 |
| DEPRESSION | 79 |
| SEROTONIN SYNDROME | 79 |
| SUICIDAL IDEATION | 74 |
| FALL | 73 |
| HEADACHE | 73 |
| VOMITING | 68 |
| FATIGUE | 64 |
| PAIN | 61 |
| DIARRHOEA | 60 |
| DIZZINESS | 53 |
| SUICIDE ATTEMPT | 52 |
| DYSPNOEA | 48 |
| ASTHENIA | 46 |
| OVERDOSE | 46 |
| TREMOR | 43 |
| HOSPITALISATION | 42 |
How to read vilazodone FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)
FAERS holds 9,764 voluntary reports linked to vilazodone (Viibryd), 2009-2025. Death is listed on 328 (3.4%). Hospitalization appears on 1,195 (12.2%). Top co-reported indication: Depression.
Mid-volume extract - treat DEATH-MARKED · HOSP-MID as signal-detection rates next to 72% of sex-coded reports are female (6,520 F / 2,551 M).
Read with vilazodone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 9,780 FAERS cases (Δ 16 heavier vs vilazodone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 9,782 FAERS cases (Δ 18 heavier vs vilazodone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 9,877 FAERS cases (Δ 113 heavier vs vilazodone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 9,899 FAERS cases (Δ 135 heavier vs vilazodone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.7 pp vs vilazodone's DEATH-MARKED): CASELOAD · HOSP-MID.
vilazodone stamps WATCHLIST · FEMALE-LED; class peers and methodology beat restating the same FAERS caveats on every effects URL.